Petros Pharmaceuticals Inc (PTPI)
0.679
+0.03
(+4.43%)
USD |
NASDAQ |
Apr 23, 16:00
0.679
0.00 (0.00%)
After-Hours: 19:52
Petros Pharmaceuticals Free Cash Flow (Quarterly): -2.260M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -2.260M |
September 30, 2023 | -4.046M |
June 30, 2023 | -0.5721M |
March 31, 2023 | -0.7484M |
December 31, 2022 | -1.570M |
September 30, 2022 | -1.752M |
June 30, 2022 | -4.200M |
March 31, 2022 | -5.276M |
Date | Value |
---|---|
December 31, 2021 | -8.304M |
September 30, 2021 | -1.211M |
June 30, 2021 | -1.900M |
March 31, 2021 | -0.4466M |
December 31, 2020 | -4.523M |
September 30, 2020 | -2.667M |
June 30, 2020 | -5.74M |
March 31, 2020 | -2.380M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-8.304M
Minimum
Dec 2021
-0.4466M
Maximum
Mar 2021
-2.975M
Average
-2.320M
Median
Free Cash Flow (Quarterly) Benchmarks
Avalo Therapeutics Inc | -2.766M |
Spectral AI Inc | -5.338M |
Imunon Inc | -3.772M |
Assembly Biosciences Inc | 73.58M |
iBio Inc | -4.706M |